Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell Lymphoma
Open Access
- 1 July 2012
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 181 (1) , 26-33
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Regulation of B-cell differentiation by microRNAs and RNA-binding proteinsBiochemical Society Transactions, 2008
- Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center BiomarkersJournal of Clinical Oncology, 2008
- Regulation of B- and T-cell differentiation by a single microRNABiochemical Society Transactions, 2008
- Hematopoietic-specific microRNA expression in human cellsLeukemia Research, 2006
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- MicroRNAsCell, 2004
- High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphomaGenes, Chromosomes and Cancer, 2003
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Identification of Tissue-Specific MicroRNAs from MouseCurrent Biology, 2002
- An Extensive Class of Small RNAs in Caenorhabditis elegansScience, 2001